Oncternal Therapeutics Inc Cash Flow-to-Debt Ratio
Oncternal Therapeutics Inc cash flow-to-debt ratio. Oncternal Therapeutics Inc (ONCT) has a Cash Flow-to-Debt Ratio of -1.08x as of September 2024, meaning its operating cash flow of $-6.95 Million could theoretically repay -1% of its total liabilities ($6.45 Million) in one year. Check ONCT cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Oncternal Therapeutics Inc (2002–2023)
Cash flow-to-debt ratio of Oncternal Therapeutics Inc from 2002 to 2023. Historical debt coverage capacity for Oncternal Therapeutics Inc across 22 annual periods. Check Oncternal Therapeutics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Oncternal Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2002–2023)
Oncternal Therapeutics Inc cash flow-to-debt ratio by year from 2002 to 2023. Year-by-year debt coverage analysis for Oncternal Therapeutics Inc. For the full cash flow conversion analysis, see Oncternal Therapeutics Inc operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2023 | -4.82x | $-32.16 Million | $6.68 Million | ▼ -0.8% |
| 2022 | -4.78x | $-36.70 Million | $7.68 Million | ▲ +1.8% |
| 2021 | -4.87x | $-26.59 Million | $5.46 Million | ▼ -62.9% |
| 2020 | -2.99x | $-17.50 Million | $5.86 Million | ▼ -32.5% |
| 2019 | -2.25x | $-16.75 Million | $7.43 Million | ▲ +70.2% |
| 2018 | -7.55x | $-39.35 Million | $5.21 Million | ▼ -156.7% |
| 2017 | -2.94x | $-23.46 Million | $7.97 Million | ▲ +34.7% |
| 2016 | -4.51x | $-20.78 Million | $4.61 Million | ▼ -578.6% |
| 2015 | -0.66x | $-20.04 Million | $30.17 Million | ▲ +24.2% |
| 2014 | -0.88x | $-28.76 Million | $32.82 Million | ▲ +90.2% |
| 2013 | -8.94x | $-43.97 Million | $4.92 Million | ▼ -142.5% |
| 2012 | -3.68x | $-37.11 Million | $10.07 Million | ▲ +29.7% |
| 2011 | -5.24x | $-33.09 Million | $6.31 Million | ▼ -115.1% |
| 2010 | -2.44x | $-30.53 Million | $12.52 Million | ▼ -252.3% |
| 2009 | -0.69x | $-46.00 Million | $66.47 Million | ▼ -1700.1% |
| 2008 | -0.04x | $-2.92 Million | $76.09 Million | ▲ +91.7% |
| 2007 | -0.47x | $-37.63 Million | $80.81 Million | ▼ -30.9% |
| 2006 | -0.36x | $-11.46 Million | $32.21 Million | ▲ +90.6% |
| 2005 | -3.77x | $-34.82 Million | $9.23 Million | ▼ -120.8% |
| 2004 | -1.71x | $-15.67 Million | $9.17 Million | ▼ -2102.2% |
| 2003 | -0.08x | $-13.00 Million | $167.54 Million | ▲ +52.0% |
| 2002 | -0.16x | $-10.55 Million | $65.34 Million | — |